Clinical Trial Update: Safety and Efficacy of the Fruit-based Product OPAL A for the Treatment of Chronic Venous and Pressure Ulcers [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the safety and efficacy of the fruit-based product OPAL A for chronic venous ulcers and pressure ulcers has been suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pressure Ulcer
• Venous Ulcer

Drugs mentioned

• OPAL A

Snippet

Sponsor: Phoenix Eagle Company | Conditions: Venous Ulcer, Pressure Ulcer | Phase 2 | Status: SUSPENDED